Stéphane Depil, founder and CEO of ErVaccine Technologies,  will give a talk  entitled “Human Endogenous Retrovirus (HERVs) Represent a Source of Shared Tumour Epitopes Inducing High Avidity Cytotoxic T cells for Cancer Immunotherapy” at European NEOANTIGEN Summit 2022 (Session “Retroviral Antigens – Uncovering a New Avenue” planned on Tuesday 26 April at 3:00 pm)

For more information visit: NEOANTIGEN Summit 2022